MDS Inc. to Announce First Quarter Results and Hold Annual and Special Meeting
07 Marzo 2006 - 1:00PM
PR Newswire (US)
TORONTO, March 7 /PRNewswire-FirstCall/ -- MDS Inc. will be
announcing its first quarter results on Thursday, March 9th and
holding its Annual and Special Meeting of Shareholders later that
day. First Quarter Results - First quarter results will be
announced the morning of Thursday, March 9th, 2006. Information
relating to the first quarter will be available at
http://www.mdsinc.com/. - The analyst and institutional investor
conference call will be held on Thursday, March 9th at 10:30 a.m.
EST. The call will be webcast live at http://www.mdsinc.com/. A
recording of the conference call will be available at
http://www.mdsintl.com/news_events/webcasts_presentations.asp or by
calling 416-695-5800 and entering access code 3171683. Media
Briefing - A media briefing with Stephen P. DeFalco, President and
Chief Executive Officer, MDS Inc. will take place on Thursday,
March 9th, 2006 at 1:00 p.m. EST at the Design Exchange, 234 Bay
Street, Toronto, Ontario, Canada. Annual and Special Meeting - The
Annual and Special Meeting will take place on Thursday, March 9th,
2006 at 4:00 p.m. EST at the Design Exchange, 234 Bay Street,
Toronto, Ontario, Canada. - The Meeting will be webcast live at
http://www.mdsinc.com/. A recording of the Meeting will be
available at
http://www.mdsintl.com/news_events/webcasts_presentations.asp. MDS
Inc. is a global life sciences company that provides market-leading
products and services that our customers need for the development
of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical
isotopes for molecular imaging, radiotherapeutics, and analytical
instruments. MDS has more than 8,800 highly skilled people in 28
countries. Find out more at http://www.mdsinc.com/ or by calling
1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Inc. CONTACT: For
Further MDS Information Contact: Yvette Lokker, Manager, Investor
Relations, (416) 675-6777 ext. 2993,
Copyright